Alzheimer’s Cure on the Horizon

Alzheimer's hope

In a recent interview with Ira Flow at NPR, Stephen Strittmatter explained his new research published in the journal Neuron.  He is Vincent Coates Professor of Neurology at Yale University’s School of Medicine and cofounder of Axerion Therapeutics, a private biotechnology company specializing in the research and development of treatments for Alzheimer’s disease.  His new study offers key insights into Alzheimer’s disease and gives hope that a cure might be on the horizon.

Since we have not proven what actually causes the disease, Strittmatter worked off the theory that Alzheimer’s disease is caused by abnormally folded proteins called amyloid oligomers.  It is believed that these toxic oligomers are the primary cause of all amyloid-related degenerative diseases.   They interact with neurons in the brain to damage synaptic function, creating memory deficits.  According to this theory, amyloid plaques build up in the brains of patients suffering from Alzheimer’s as a result of these protein interactions.  Strittmatter focused his study on figuring out exactly how these irregularly folded proteins interact with the neurons.  They already knew that the bad proteins interact with prion proteins on the neuron’s surface, but they didn’t know how the interaction was communicated to the inside of the cell.

The study’s main discovery was the protein called mGlur5 or Metabotropic Glutamate Receptor Five.  It is the protein responsible for the communication between the abnormally folded proteins and the inside of the neurons in the brain, triggering the internal chemistry that changes the synapses causing the neuron to lose synaptic function.  In essence, the protein mGlur5 crosses the cell membrane of the neuron and activates changes on the inside of the cell triggered by the bad, misfolded proteins causing the damage to the synapse.  Additionally, Strittmater found that blocking the mGlur5 protein using a drug called MTEP not only prevents the damage to the neuron, but may even reverse the loss of synaptic function, bringing back the lost memory.  This new knowledge of Alzheimer’s means a cure could be on the horizon.

Strittmatter was quick to point out that, in these early stages, use of the drug is not a current option for Alzheimer’s patients.  The mGlur5 protein is necessary for normal brain function and too much of the drug could shut down normal, healthy synaptic processes in the brain.  The hope is to develop a drug that will selectively inhibit the mGlur5 protein being triggered by the bad proteins and still allow mGlur5 to perform its normal processes.

The fact that the mice in the study recovered cognitive functions is actually quite remarkable.  The mice represent a patient in the earliest stages of the disease.  Their brains had lost synaptic function, but had no actual cell death.  A reversal of cell death would not be expected given this treatment option.  However, with the development of this drug on the horizon, a cure for patients in the early stages of Alzheimer’s disease could soon follow.  Recovery of lost memory function would be an incredible leap forward in the treatment of this disease affecting over five million Americans to date.

Written By: Danyelle C. Overbo

Source 1

Source 2

Source 3

We will read your comment immediately so leave a remark!

RSS Guardian Express

  • Iranian Messi a Target for European Elite: World Cup Preview [Video] April 20, 2014
    A number of Europe’s elite clubs are targeting a young forward dubbed the “Iranian Messi” before he is selected to represent his country at the 2014 World Cup. Rubin Kazan forward Sardar Azmoun is a rising star and he is tipped to win senior honors at the big event in Brazil. Premier League side Arsenal […]
    Robert Shepherd
  • Los Angeles Times Building Scare April 20, 2014
    A scare at the Los Angeles Times building resulted in a lockdown and search of the entire premises. Suspect, Matthew Lowes, was detained by police and taken without incident from the second floor of the building. The second floor of the Times building has space rented by VXI Global Solutions, which Lowes works for. Lowes […]
    Raul Hernandez
  • Indiana Pacers Struggles Continue April 20, 2014
    The Indiana Pacers’ late-season struggles continued as the team lost to the visiting Atlanta Hawks yesterday by a score of 101-93. When the team is playing its best, the offense features a balanced attack. In order for the offense to hum, the team needs balanced scoring from the inside and outside. Against the Hawks, Roy […]
    William Costolo
  • Influenza B Virus Making a Strong Spring Appearance April 20, 2014
    The Influenza strain B virus is making a strong appearance, although spring is not its usual time of year. This strain of the flu is not the same one that was making people sick mid-winter. This means that even if someone has already had the virus once this flu season, they can still get it […]
    Twanna Harps
  • Toronto Raptors Have Bitten Off More Than They Can Chew April 20, 2014
    If you look at the day the city of Toronto and their beloved Toronto Raptor’s had, it would be really easy to come to the conclusion that the  Toronto Raptors have bitten off more than they can chew. Toronto Sun Times readers were greeted with an incendiary cover , featuring a picture of Kevin Garnett […]
    Daryl McElveen

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 629 other subscribers

Quantcast